Back
Voya Global Advantage and Premium Opportunity Fund Vs. Nutex Health Industry Stock Comparison
Buy
59
IGA
Voya Global Advantage and Premium Opportunity Fund
Last Price:
$9.58
Seasonality Move:
0.94%
Sell
30
NUTX
Nutex Health
Last Price:
$46.71
Seasonality Move:
-2.28%
Buy
59
Voya Global Advantage and Premium Opportunity Fund (IGA)
is a Buy
Is Voya Global Advantage and Premium Opportunity Fund a Buy, Sell or Hold?
-
The current Voya Global Advantage and Premium Opportunity Fund [IGA] share price is $9.57. The Score for IGA is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
IGA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Nutex Health (NUTX)
is a Sell
Is Nutex Health a Buy, Sell or Hold?
-
The current Nutex Health [NUTX] share price is $45.85. The Score for NUTX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
NUTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IGA Stock Price Chart
What is Voya Global Advantage and Premium Opportunity Fund's stock price today?
-
The Voya Global Advantage and Premium Opportunity Fund share price today is $9.57The current trend is moderately bearish and IGA is experiencing slight selling pressure.
NUTX Stock Price Chart
What is Nutex Health's stock price today?
-
The Nutex Health share price today is $45.85Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
IGA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 48.05 | Sell |
Chaikin Money Flow: | -13032 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.45 - 9.71) | Sell |
Bollinger Bands (100): | (9.33 - 9.63) | Buy |
NUTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.44 | Sell |
Relative Strength Index (14 RSI): | 43.94 | Sell |
Chaikin Money Flow: | 34074 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.93 - 61.65) | Sell |
Bollinger Bands (100): | (25.44 - 49.32) | Buy |
IGA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.66 | Sell |
20-day SMA: | 9.64 | Sell |
50-day SMA: | 9.48 | Buy |
200-day SMA: | 9.3 | Buy |
8-day EMA: | 9.64 | Sell |
20-day EMA: | 9.62 | Sell |
50-day EMA: | 9.54 | Buy |
200-day EMA: | 9.3 | Buy |
NUTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.57 | Sell |
20-day SMA: | 55.51 | Sell |
50-day SMA: | 45.34 | Buy |
200-day SMA: | 24.99 | Buy |
8-day EMA: | 48.61 | Sell |
20-day EMA: | 51.17 | Sell |
50-day EMA: | 46.8 | Sell |
200-day EMA: | 34.46 | Buy |
Voya Global Advantage and Premium Opportunity Fund Earnings Growth & IGA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nutex Health Earnings Growth & NUTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.74 per share, and an increase next year of $1.17 per share.
Voya Global Advantage and Premium Opportunity Fund Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nutex Health Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |